BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28535647)

  • 21. Dissimilar microRNA-21 functions and targets in trophoblastic cell lines of different origin.
    Chaiwangyen W; Ospina-Prieto S; Photini SM; Schleussner E; Markert UR; Morales-Prieto DM
    Int J Biochem Cell Biol; 2015 Nov; 68():187-96. PubMed ID: 26320576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mir-22-3p Enhances the Chemosensitivity of Gastrointestinal Stromal Tumor Cell Lines to Cisplatin through PTEN/PI3K/Akt Pathway.
    Xu Y; Cheng M; Mi L; Qiu Y; Hao W; Li L
    Iran J Allergy Asthma Immunol; 2018 Aug; 17(4):318-325. PubMed ID: 30537795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restoration of miR-152 expression suppresses cell proliferation, survival, and migration through inhibition of AKT-ERK pathway in colorectal cancer.
    Ghazanchaei A; Mansoori B; Mohammadi A; Biglari A; Baradaran B
    J Cell Physiol; 2018 Jan; 234(1):769-776. PubMed ID: 30076720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological function and mechanism of miR-33a in prostate cancer survival and metastasis: via downregulating Engrailed-2.
    Li Q; Lu S; Li X; Hou G; Yan L; Zhang W; Qiao B
    Clin Transl Oncol; 2017 May; 19(5):562-570. PubMed ID: 27921232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells.
    Dixon KM; Lui GY; Kovacevic Z; Zhang D; Yao M; Chen Z; Dong Q; Assinder SJ; Richardson DR
    Br J Cancer; 2013 Feb; 108(2):409-19. PubMed ID: 23287991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer.
    Wu YR; Qi HJ; Deng DF; Luo YY; Yang SL
    Tumour Biol; 2016 Sep; 37(9):12061-12070. PubMed ID: 27188433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of miR-32 targeting PTEN on proliferation and apoptosis of myeloma cells.
    Sun YY; Pan J; Wei W; Yu SS; Mao SD; Zhang N; Ai LM
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3509-3516. PubMed ID: 32329824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.
    Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N
    Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-205 inhibits cell apoptosis by targeting phosphatase and tensin homolog deleted on chromosome ten in endometrial cancer Ishikawa cells.
    Zhang G; Hou X; Li Y; Zhao M
    BMC Cancer; 2014 Jun; 14():440. PubMed ID: 24929707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The regulatory role of icariin on apoptosis in mouse preimplantation embryos with reduced microRNA-21.
    Zhang C; Shi YR; Liu XR; Cao YC; Tian JL; Jia ZY; Zhen D; Liu FH; Gao JM
    Theriogenology; 2014 Aug; 82(3):461-8. PubMed ID: 24948525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way.
    Zhang X; Wang D; Liu B; Jin X; Wang X; Pan J; Tu W; Shao Y
    J Exp Clin Cancer Res; 2020 Sep; 39(1):190. PubMed ID: 32938489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-143 Induces the Apoptosis of Prostate Cancer LNCap Cells by Suppressing Bcl-2 Expression.
    Ma Z; Luo Y; Qiu M
    Med Sci Monit; 2017 Jan; 23():359-365. PubMed ID: 28109198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
    Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
    Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Su S; Luo D; Liu X; Liu J; Peng F; Fang C; Li B
    Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28842516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-1297 Promotes Cell Proliferation of Non-Small Cell Lung Cancer Cells: Involving in PTEN/Akt/Skp2 Signaling Pathway.
    Bu W; Luo T
    DNA Cell Biol; 2017 Nov; 36(11):976-982. PubMed ID: 28872922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling.
    Conley-LaComb MK; Saliganan A; Kandagatla P; Chen YQ; Cher ML; Chinni SR
    Mol Cancer; 2013 Jul; 12(1):85. PubMed ID: 23902739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-modulation of Bcl-2 sensitizes PTEN-mutated prostate cancer cells to starvation and taxanes.
    Calastretti A; Gatti G; Quaresmini C; Bevilacqua A
    Prostate; 2014 Oct; 74(14):1411-22. PubMed ID: 25111376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit.
    Bertacchini J; Mediani L; Beretti F; Guida M; Ghalali A; Brugnoli F; Bertagnolo V; Petricoin E; Poti F; Arioli J; Anselmi L; Bari A; McCubrey J; Martelli AM; Cocco L; Capitani S; Marmiroli S
    J Cell Physiol; 2019 Jul; 234(7):11188-11199. PubMed ID: 30565691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-25 inhibits high glucose-induced apoptosis in renal tubular epithelial cells via PTEN/AKT pathway.
    Li H; Zhu X; Zhang J; Shi J
    Biomed Pharmacother; 2017 Dec; 96():471-479. PubMed ID: 29031207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.